Results 341 to 350 of about 379,925 (396)
Some of the next articles are maybe not open access.
Thyroid, 2019
Background: Some patients with metastatic differentiated thyroid cancer (DTC) lack iodine avidity and are therefore unsuitable for radioactive iodine (RAI) therapy. Limited experience suggests that single-agent selective mitogen-activated protein kinase (
A. Iravani +8 more
semanticscholar +1 more source
Background: Some patients with metastatic differentiated thyroid cancer (DTC) lack iodine avidity and are therefore unsuitable for radioactive iodine (RAI) therapy. Limited experience suggests that single-agent selective mitogen-activated protein kinase (
A. Iravani +8 more
semanticscholar +1 more source
Recurrent Differentiated Thyroid Cancer
Endocrine Practice, 2012To discuss the risk of recurrence in patients with differentiated thyroid cancer and emphasize the importance of risk-group stratification.Common risk factors associated with recurrent thyroid cancer are outlined, and appropriate management strategies are reviewed.The overall prognosis in patients with differentiated thyroid cancer is excellent ...
openaire +2 more sources
Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update.
AJR. American journal of roentgenology, 2020OBJECTIVE. The paradigm of theranostics is based on tailoring therapy for the purpose of optimizing outcomes. This principle is being applied to radioactive iodine therapy. Consequently, thyroid cancer therapy protocols are evolving.
A. Ciarallo, J. Rivera
semanticscholar +1 more source
Well differentiated thyroid cancer
Current Opinion in Oncology, 2003Cancers of follicular cell origin are the most common of the endocrine malignancies. Thyroid cancers are seen with increased frequency after radiation exposure and in some familial syndromes. Interestingly, the prognosis of thyroid carcinoma is highly dependent on the age of the patient at the time of examination: several clinical staging systems ...
openaire +2 more sources
Differentiated thyroid cancer – 2009
Orvosi Hetilap, 2011Three years ago continental guidelines were published referring management and follow-up of low risk thyroid cancer patients. The aim of this paper is to summarize the changes and new directions in this field. High risk patients require another protocol. Neck ultrasound plays important role in differential diagnosis and in detecting recurrences.
openaire +2 more sources
Thyroid, 2018
Background: The American Joint Committee on Cancer Cancer Staging System for differentiated thyroid cancer has been recently revised. The purpose of this study was to compare survival prognostication between the seventh and eighth editions. Materials and
S. Tam +15 more
semanticscholar +1 more source
Background: The American Joint Committee on Cancer Cancer Staging System for differentiated thyroid cancer has been recently revised. The purpose of this study was to compare survival prognostication between the seventh and eighth editions. Materials and
S. Tam +15 more
semanticscholar +1 more source
Thyroid Isthmusectomy for Well-Differentiated Thyroid Cancer
Annals of Surgical Oncology, 2010The American Thyroid Association guidelines do not mention isthmusectomy as an appropriate procedure for thyroid cancer. Despite this, a small number of patients present with lesions isolated to the thyroid isthmus, which can be excised without exploring the trachyesophageal grooves or total thyroidectomy. This study was designed to analyze outcomes in
Iain J, Nixon +6 more
openaire +2 more sources
Radioiodine Refractory Differentiated Thyroid Cancer
2022Patients with radioactive iodine (RAI) refractory locally advanced or metastatic differentiated thyroid cancer have a poor prognosis. This article reviews the definition of RAI-refractory thyroid cancer and the management approach. Watchful waiting should be considered for patients with asymptomatic and non-progressive disease, while oral targeted ...
Wendy W L, Chan +2 more
openaire +2 more sources
Differentiated thyroid cancer in children
Head & Neck Surgery, 1985AbstractDifferentiated thyroid cancer in children remains a controversial disease entity. Its incidence has markedly declined over the last decade since the use of radiotherapy in the treatment of benign conditions of the head, neck, and thorax was abandoned. Other etiologic factors have become relatively more important.
L F, De Keyser, A J, Van Herle
openaire +2 more sources
Head and Neck, 2019
Multitarget kinase inhibitors (m‐TKI), including lenvatinib, are now available as treatment options for radioiodine‐refractory differentiated thyroid cancer (RR‐DTC).
C. Suzuki +12 more
semanticscholar +1 more source
Multitarget kinase inhibitors (m‐TKI), including lenvatinib, are now available as treatment options for radioiodine‐refractory differentiated thyroid cancer (RR‐DTC).
C. Suzuki +12 more
semanticscholar +1 more source